B2BROKER
17.2.2020 11:02:04 CET | Business Wire | Press release
B2Broker , a leading liquidity and technology provider of solutions to the forex and crypto industry, is pleased to introduce B2Core , a major upgrade to its client cabinet solution Trader’s Room, which has undergone a major overhaul in response to client demand and to meet today’s exacting business needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005010/en/
All New Client Cabinet Concept
B2Core takes on a whole new guise embracing a vast new range of new capabilities, culminating in an innovative and unique bespoke service for clients. B2Core offers an all-round, greatly improved user experience compared with the company’s previous version. It consolidates all previous aspects of Traders room, including clients area, etc, elevating the company’s existing SaaS solution to the top of its league in the financial services industry.
Businesses looking for a solution with functionality that can handle a broader and more customised range of demands than the industry-standard traders room solution will find B2Core exceeds their expectations and outperforms other products in the market with a range of advanced features that can be tailored to fit each type of organisation. With B2Core, businesses no longer need to accept a one-size-fits-all solution.
Unique Pack-Based Solution
From basic tasks such as organising the work of forex brokers and crypto exchanges, back office for employees and administrators, front-end for traders, verification and registration of customers and a huge range of payment functions, B2Core brings to the market a whole new concept of a pack-based solution.
This essentially means that B2Core clients can now choose a package that suits their requirements best. For example, the B2Core Standard pack includes a basic set of features and offers a budget-friendly solution. Alternatively, businesses can opt for an Advanced pack with many more potential features and modules such as bonuses, IB Room and Converter, and integrations with a large choice of payment solutions and external platforms such as B2Trader, MetaTrader, CTrader, dxTrade, AlphaPoint, OneZero and PrimeXM.
At the top end of the scale for larger corporates, B2Core offers an Enterprise pack, a solution which is ideal for where the client has their own specific requirements and demands regarding the type of solution they want. In this respect, B2Broker develops and maintains the solution accordingly.
The newly adapted B2Core pack-based solution means that B2Broker can offer a product which is more responsive to its clients requirements and more flexible in that the solution can be adjusted to meet a wide range of needs.
B2Core is a must-have choice for any professional business including FX and crypto brokers, converters, spot and margin exchanges, EMIs and crypto wallets, adding an extra dimension to the existing Trader’s Room offering with the following all-important features:
Dynamic Advanced UI Layout
The first of the new features is an ideal opportunity for all Exchange clients to obtain one of the most advanced front-end layouts on the market. The end-user of the Exchange will be able to fully customize the workspaces in order to maximize the efficiency of their trading performance and combine it with the satisfaction of usage.
For example, users can now organize the blocks of order books, watchlist, charts, history of trades, change the size and order of these windows without any limitations to get the best usability and maximum customization of the platform. It is also possible to create several workspaces to enable users to have separate areas for different trading purposes.
Another new feature is Market Depth which shows the market's ability to sustain relatively large market orders without impacting on the price of the asset in question. Market depth takes into consideration the overall level and breadth of current open orders within an individual currency pair.
Grouping of volumes is a significant part of the update which allows users to analyze the deepest liquidity available on the platform. It can be accessed in the order book of every instrument.
Finally, the Watchlist widget can now be added to the workspaces of the Trading UI. Users are able to make a list of the pairs that they wish to monitor and display the current prices, volumes and 24 hour highs & lows in one place.
Overall, the Trading UI is now capable of fulfilling all the demands of professional traders who frequently use it to monitor large amounts of information.
Advanced Anti-Fraud Homemade System
B2Core’s Advanced Anti-Fraud Homemade System is an automatic withdrawals system featuring security alerts and other procedures to avoid money-laundering and trading cheating procedures on the platform.
Sum-Sub WebSDK Integration
Sum-Sub WebSDK integration provides advanced and highly customizable Know Your Customer (KYC) procedures that will enable a business owner to avoid legal department costs as everything is handled automatically by the technology provider.
PrimeXM/OneZero Integration
As well as deep integration with the industry’s flagship trading platform MetaTrader 4 and 5, B2Core is now integrated with PrimeXM, OneZero, dxTrade and B2Trader, making a total of 6 trading platforms. B2Broker can now offer its customers the opportunity to target a wider range of end-customers across the globe.
Ticket System
B2Core, currently integrated with SupportPal, can now enable clients to offer a ticket-based customer support service within B2Core as a module. Rather than conducting support via Skype and other social networks where information is likely to get lost, using the Ticket System ensures everything is recorded and processed as part of the same procedure.
Detailed MT Analytics
B2Core’s main trading platform integration with MT 4 & 5 allows the end-users to monitor all activities occurring on the MT account directly from their Trader’s Room account. This allows the user to check his requirement and actions with one solution as illustrated:
Withdrawal Address Whitelist
A new whitelist function has been added which is essentially an address whitelist for withdrawal purposes. This is an additional security measure for end users, where they are able to specify their chosen, trusted wallets for withdrawal which means that only these wallets will be logged out of the system. The new security measure has been developed in conjunction with 2FA Google Authenticator.
A Multi-Featured Package To Suit Every Business Need
All in all, B2Core offers a huge range of vital new adjustable features, providing users with the means to pick and choose what suits them. It is the must-have solution for every company and one which is capable of handling client-facing operations of every type of financial business, regardless of complexity. Not only is B2Core highly-customisable, it is an efficient, high-performance system that overrides all the one-size-fits-all client cabinet solutions in the market, and most importantly, one which your users will thank you for choosing.
About B2Broker
B2Broker is a liquidity and technology provider of solutions for the crypto and foreign exchange (FX) industry. The company specialises in the sphere of B2B services and products, catering for a wide range of clients including large licensed brokers, crypto exchanges, crypto brokers, forex brokers, hedge and crypto funds and professional managers.
B2Broker’s advanced base of ready to use technical solutions enable brokers to save time and money on consuming infrastructure projects and focus on enlarging their client base and increasing their revenues.
Please contact B2Broker to enhance your company with B2Core.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200217005010/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
